Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Gastroenterology - Germany
doi 10.1007/s00535-016-1263-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gemcitabine Plus Carboplatin in Patients With Advanced Hepatocellular Carcinoma: Results of a Phase II Study

ISRN Oncology
2012English

Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study

Drugs - Real World Outcomes
Pharmacology
2020English

Carnitine Insufficiency Is Associated With Fatigue During Lenvatinib Treatment in Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2020English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib

Hepatology Research
HepatologyInfectious Diseases
2019English

A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2014English

Thymostimulin in Advanced Hepatocellular Carcinoma: A Phase II Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

High Immunosuppressive Burden in Advanced Hepatocellular Carcinoma Patients

OncoImmunology
OncologyAllergyImmunology
2013English

Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma

Future Oncology
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy